In breast cancer, patients with disseminated tumor cells in the bone marrow tend to express higher levels of HIF1α in their primary tumors [360], suggesting that HIF1α signaling may promote tumor dissemination to the bone marrow. This evidence concerns the gene HIF1A and neoplasm.